⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10045288 | 1.00 | — | — | |
| SCHEMBL11934544 | 1.00 | — | — | |
| SCHEMBL14021805 | 0.86 | — | — | |
| SCHEMBL14723791 | 0.85 | — | — | |
| SCHEMBL11937055 | 0.85 | — | — | |
| SCHEMBL11913589 | 0.84 | — | — | |
| SCHEMBL11934549 | 0.83 | — | — | |
| SCHEMBL403204 | 0.83 | — | — | |
| SCHEMBL10045290 | 0.83 | — | — | |
| SCHEMBL10357880 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023603-B2 | Preparation of monosaccharides, disaccharides, trisaccharides, and pentasaccharides of heparinoids | FORMOSA LABORATORIES, INC. (TW) | 2018-07-17 | — | — | US | disclosed |
| US-20170015695-A1 | PREPARATION OF MONOSACCHARIDES, DISACCHARIDES, TRISACCHARIDES, AND PENTASACCHARIDES OF HEPARINOIDS | FORMOSA LABORATORIES, INC. (TW) | 2017-01-19 | — | — | US | disclosed |
| US-20160310521-A1 | POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS | SANOFI (FR) | 2016-10-27 | — | — | US | disclosed |
| US-9243018-B2 | Synthetic heparin pentasaccharides | DR. REDDY'S LABORATORIES, SA (CH) | 2016-01-26 | — | — | US | disclosed |
| US-9089484-B2 | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration | MERRION RESEARCH III LIMITED (IE) | 2015-07-28 | — | — | US | disclosed |
| US-20150005485-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2015-01-01 | — | — | US | disclosed |
| US-20140336369-A1 | PROCESS FOR PREPARING HEPARINOIDS AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF | APICORE US LLC (US) | 2014-11-13 | — | — | US | disclosed |
| US-8574544-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8535640-B1 | Pharmaceutical composition of nanoparticles | GP MEDICAL, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8501711-B2 | Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-20090142405-A1 | Nanoparticles for protein drug delivery | NANOMEGA MEDICAL CORPORATION | 2009-06-04 | — | — | US | disclosed |
| US-7541445-B2 | Synthetic heparin pentasaccharides | ALCHEMIA LIMITED (AU) | 2009-06-02 | — | — | US | disclosed |
| US-7541046-B1 | Nanoparticles for protein drug delivery | GP MEDICAL, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20090011008-A1 | Nanoparticles for protein drug delivery | NANOMEGA MEDICAL CORPORATION | 2009-01-08 | — | — | US | disclosed |
| US-20090004266-A1 | Nanoparticles for protein drug delivery | NANOMEGA MEDICAL CORPORATION | 2009-01-01 | — | — | US | disclosed |
| US-7455830-B2 | Nanoparticles for protein drug delivery | GP MEDICAL, INC. (US) | 2008-11-25 | — | — | US | disclosed |
| US-20080233200-A1 | Nanoparticles for protein drug delivery | NANOMEGA MEDICAL CORPORATION | 2008-09-25 | — | — | US | disclosed |
| US-20080160078-A1 | Nanoparticles for drug delivery | GP MEDICAL, INC. | 2008-07-03 | — | — | US | disclosed |
| US-7381716-B2 | Nanoparticles for protein drug delivery | GP MEDICAL, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-20070116771-A1 | Nanoparticles for protein drug delivery | NANOMEGA MEDICAL CORPORATION | 2007-05-24 | — | — | US | disclosed |